Scott E. Woodman

Active 2000–2025

62
Papers
24,440
Citations
51
h-index
61
i10-index

Citations

Citations per year for Scott E. Woodman1959: 1 citations1966: 1 citations2000: 4 citations2001: 13 citations2002: 22 citations2003: 68 citations2004: 105 citations2005: 75 citations2006: 59 citations2007: 80 citations2008: 67 citations2009: 68 citations2010: 69 citations2011: 80 citations2012: 87 citations2013: 80 citations2014: 83 citations2015: 80 citations2016: 102 citations2017: 244 citations2018: 390 citations2019: 1,118 citations2020: 1,599 citations2021: 1,645 citations2022: 1,461 citations2023: 1,209 citations2024: 1,530 citations2025: 948 citations2026: 29 citations1960–1965: no citations, so these years are not shown1967–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,012 citing papers, 27.8% of this breakdownChina: 2,583 citing papers, 17.9% of this breakdownUnited Kingdom: 685 citing papers, 4.7% of this breakdownItaly: 672 citing papers, 4.7% of this breakdownFrance: 616 citing papers, 4.3% of this breakdownGermany: 602 citing papers, 4.2% of this breakdownAustralia: 430 citing papers, 3% of this breakdownCanada: 427 citing papers, 3% of this breakdownNetherlands: 418 citing papers, 2.9% of this breakdownJapan: 390 citing papers, 2.7% of this breakdownSpain: 332 citing papers, 2.3% of this breakdownSwitzerland: 273 citing papers, 1.9% of this breakdown
0%27.8%Other 20.6%

Fields

  • Medicine48.6%
  • Biochemistry, Genetics and Molecular Biology38.3%
  • Immunology and Microbiology9.8%
  • Neuroscience0.9%
  • Engineering0.8%
  • Agricultural and Biological Sciences0.3%
  • Other1.3%

Topics

  • Cancer Immunotherapy and Biomarkers13.8%
  • Immunotherapy and Immune Responses6.1%
  • Gut microbiota and health5.7%
  • Immune Cell Function and Interaction4%
  • CAR-T cell therapy research3.9%
  • Immune cells in cancer3%
  • Other63.5%

Coauthors

All papers

Open in search
  1. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pablo C. Okhuysen, V. Behrana Jensen, Alton G. Swennes, Florencia McAllister, Erick Riquelme, Yexi Zhang, Emmanuelle Le Chatelier, Laurence Zitvogel, Nicolas Pons, Jacob L. Austin-Breneman, Lauren E. Haydu, Elizabeth M. Burton, Julie M. Gardner, Elizabeth Sirmans, Jiemiao Hu, Alexander J. Lazar, Takahiro Tsujikawa, Adi Diab, Hussein A. Tawbi, Isabella C. Glitza, Wen-Jen Hwu, Sapna P. Patel, Scott E. Woodman, Rodabe N. Amaria, Michael A. Davies, Jeffrey E. Gershenwald, Patrick Hwu, J. E. Lee, J. Zhang, Lisa M. Coussens, Zachary A. Cooper, P. Andrew Futreal, Carrie R. Daniel, Nadim J. Ajami, Joseph F. Petrosino, Michael T. Tetzlaff, Padmanee Sharma, James P. Allison, Robert R. Jenq, Jennifer A. Wargo - Science 2017 cited by 4,788

  2. B cells and tertiary lymphoid structures promote immunotherapy response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine N. Spencer, Elizabeth M. Burton, Lauren E. Haydu, Alexander J. Lazar, Roberta Zapassodi, Courtney W. Hudgens, Deborah A. Ledesma, SuFey Ong, Michael Bailey, Sarah Warren, Disha Rao, Oscar Krijgsman, Elisa A. Rozeman, Daniel S. Peeper, Christian U. Blank, Ton N. Schumacher, Lisa H. Butterfield, Monika A. Zelazowska, Kevin M. McBride, Raghu Kalluri, James P. Allison, Florent Petitprez, Wolf H. Fridman, Catherine Sautès‐Fridman, Nir Hacohen, Katayoun Rezvani, Padmanee Sharma, Michael T. Tetzlaff, Linghua Wang, Jennifer A. Wargo - Nature 2020 cited by 2,745

  3. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mohamed A. Jamal, Erez N. Baruch, Eva Pérez‐Guijarro, Chi‐Ping Day, Glenn Merlino, Barbara Pazdrak, Brooke S. Lochmann, Robert Szczepaniak‐Sloane, Reetakshi Arora, Jaime Anderson, Chrystia M. Zobniw, Eliza Posada, Elizabeth Sirmans, Julie M. Simon, Lauren E. Haydu, Elizabeth M. Burton, Linghua Wang, Minghao Dang, Karen Clise-Dwyer, Sarah Schneider, Thomas Chapman, Nana-Ama A.S. Anang, Sheila Duncan, Joseph Toker, Jared Malke, Isabella C. Glitza, Rodabe N. Amaria, Hussein A. Tawbi, Adi Diab, Michael K. Wong, Sapna P. Patel, Scott E. Woodman, Michael A. Davies, Merrick I. Ross, Jeffrey E. Gershenwald, Jeffrey E. Lee, Patrick Hwu, V. Behrana Jensen, Yardena Samuels, Ravid Straussman, Nadim J. Ajami, Kelly C. Nelson, Luigi Nezi, Joseph F. Petrosino, P. Andrew Futreal, Alexander J. Lazar, Jianhua Hu, Robert R. Jenq, Michael T. Tetzlaff, Yan Yan, Wendy S. Garrett, Curtis Huttenhower, Padmanee Sharma, Stephanie S. Watowich, James P. Allison, Lorenzo Cohen, Giorgio Trinchieri, Carrie R. Daniel, Jennifer A. Wargo - Science 2021 cited by 932

  4. Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Timothy P. Heffernan, Jianhua Hu, Roland L. Bassett, Marcus Bosenberg, Scott E. Woodman, Willem W. Overwijk, Gregory Lizée, Jason Roszik, Thomas F. Gajewski, Jennifer A. Wargo, Jeffrey E. Gershenwald, Laszlo Radvanyi, Michael A. Davies, Patrick Hwu - Cancer Discovery 2015 cited by 1,531

  5. Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy

    Authors: , , , , , , , , , , , , , , , - Cell 2016 cited by 1,316

  6. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Khalida Wani, Alexander J. Lazar, Michael T. Tetzlaff, Courtney W. Hudgens, Margaret K. Callahan, Matthew Adamow, Michael A. Postow, Charlotte E. Ariyan, Pierre-Olivier Gaudreau, Luigi Nezi, Didier Raoult, Catalin Mihalcioiu, Arielle Elkrief, Rossanna C. Pezo, Lauren E. Haydu, Julie M. Simon, Hussein A. Tawbi, Jennifer L. McQuade, Patrick Hwu, Wen-Jen Hwu, Rodabe N. Amaria, Elizabeth M. Burton, Scott E. Woodman, Stephanie S. Watowich, Adi Diab, Sapna P. Patel, Isabella C. Glitza, Michael K.K. Wong, Li Zhao, Jianhua Zhang, Nadim J. Ajami, Joseph F. Petrosino, Robert R. Jenq, Michael A. Davies, Jeffrey E. Gershenwald, P. Andrew Futreal, Padmanee Sharma, James P. Allison, Bertrand Routy, Laurence Zitvogel, Jennifer A. Wargo - Nature Medicine 2021 cited by 415

  7. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rodabe N. Amaria, Lawrence N. Kwong, Víctor G. Prieto, R. Eric Davis, Wencai Ma, Willem W. Overwijk, Arlene H. Sharpe, Jianhua Hu, P. Andrew Futreal, Jorge Blando, Padmanee Sharma, James P. Allison, Lynda Chin, Jennifer A. Wargo - Cancer Discovery 2016 cited by 1,008

  8. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liberty Posada, Lauren E. Haydu, Linghua Wang, Shaojun Zhang, Alexander J. Lazar, Courtney W. Hudgens, Vancheswaran Gopalakrishnan, Alexandre Reuben, Miles C. Andrews, Christine N. Spencer, Víctor G. Prieto, Padmanee Sharma, James P. Allison, Michael T. Tetzlaff, Jennifer A. Wargo - Nature Medicine 2018 cited by 826

  9. Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott E. Woodman, Jason Roszik, R. Eric Davis, Michael A. Davies, John V. Heymach, Patrick Hwu, Weiyi Peng - Cell Metabolism 2018 cited by 624

  10. Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott E. Woodman, Rodabe N. Amaria, Víctor G. Prieto, Jianhua Hu, Padmanee Sharma, James P. Allison, Lynda Chin, Jianhua Zhang, Jennifer A. Wargo, P. Andrew Futreal - Science Translational Medicine 2017 cited by 920

  11. CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott E. Woodman, Vassiliki A. Papadimitrakopoulou, Ethan Dmitrovsky, Jing Wang, Stephen E. Ullrich, Ignacio I. Wistuba, John V. Heymach, F. Xiao‐Feng Qin, Don L. Gibbons - Cancer Discovery 2018 cited by 471

  12. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guang R. Gao, Hiya Banerjee, Mike Lau, Jeffrey E. Gershenwald, Anthony Lucci, Emily Z. Keung, Merrick I. Ross, Laura Pala, Eleonora Pagan, Rossana Lazcano Segura, Qian Liu, Mikayla Borthwick, Eric Lau, Melinda S. Yates, Shannon N. Westin, Khalida Wani, Michael T. Tetzlaff, Lauren E. Haydu, Mikhila Mahendra, Xiao-Yan Ma, Christopher J. Logothetis, Zachary Kulstad, Sarah B. Johnson, Courtney W. Hudgens, Ningping Feng, Lorenzo Federico, Georgina V. Long, P. Andrew Futreal, Swathi Arur, Hussein A. Tawbi, Amy E. Moran, Linghua Wang, Timothy P. Heffernan, Joseph R. Marszalek, Jennifer A. Wargo - Nature 2022 cited by 130

  13. Uveal melanoma: From diagnosis to treatment and the science in between

    Authors: , , , , , , , , , , - Cancer 2016 cited by 444

  14. The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2015 cited by 582

  15. BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Antitumor Activity of Adoptive Immunotherapy in Mice

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2012 cited by 379

  16. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander M.M. Eggermont, Michael A. Davies, Miles C. Andrews, Donald A. Berry, Matthew S. Block, Genevieve M. Boland, Kathryn Bollin, Matteo S. Carlino, Richard D. Carvajal, Jonathan Cohen, Diwakar Davar, Keith A. Delman, Reinhard Dummer, Michael D. Farwell, David E. Fisher, Alberto Fusi, Isabella C. Glitza, Tanja D. de Gruijl, David Gyorki, Axel Hauschild, Tina J. Hieken, James Larkin, David H. Lawson, Célèste Lebbé, Jeffrey E. Lee, Michael Lowe, Jason J. Luke, Grant A. McArthur, David F. McDermott, Jennifer L. McQuade, Tara C. Mitchell, Teresa M. Petrella, Peter A. Prieto, Igor Puzanov, Caroline Robert, April K.S. Salama, Shaneen Sandhu, Dirk Schadendorf, Alexander N. Shoushtari, Jeffrey A. Sosman, Susan M. Swetter, Ken K Tanabe, Samra Turajlic, Douglas S. Tyler, Scott E. Woodman, Frances C. Wright, Jonathan S. Zager, Paolo A. Ascierto, Andrew J. Spillane, Alexander C. J. van Akkooi, Jennifer A. Wargo, Christian U. Blank, Hussein A. Tawbi, Georgina V. Long - The Lancet Oncology 2019 cited by 218

  17. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth M. Burton, Sangeetha M. Reddy, Padmanee Sharma, James P. Allison, Phillip Andrew Futreal, Scott E. Woodman, Michael A. Davies, Jennifer A. Wargo - The Lancet Oncology 2018 cited by 290

  18. Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabella C. Glitza, Hussein A. Tawbi, Michael K. Wong, Suzanne Cain, Merrick I. Ross, Jeffrey E. Lee, Jeffrey E. Gershenwald, Anthony Lucci, Richard E. Royal, Janice N. Cormier, Jennifer A. Wargo, Laszlo Radvanyi, Carlos A. Torres‐Cabala, Rameen Beroukhim, Patrick Hwu, Rodabe N. Amaria, Chantale Bernatchez - Clinical Cancer Research 2018 cited by 135

  19. Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2018 cited by 192

  20. Caveolae: From Cell Biology to Animal Physiology

    Authors: , , - Pharmacological Reviews 2002 cited by 983

  21. Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas

    Authors: , , , , , , , , , , , , , , , , - Clinical Cancer Research 2013 cited by 223

  22. Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John F. Thompson, Jeffrey E. Lee, Patrick Hwu, Nadim J. Ajami, Jeffrey E. Gershenwald, Georgina V. Long, Richard A. Scolyer, Michael T. Tetzlaff, Alexander J. Lazar, Dirk Schadendorf, Jennifer A. Wargo, John M. Kirkwood, Ralph J. DeBerardinis, Han Liang, P. Andrew Futreal, Jianhua Zhang, James S. Wilmott, Weiyi Peng, Michael A. Davies, Greg M. Delgoffe, Yana G. Najjar, Jennifer L. McQuade - Clinical Cancer Research 2022 cited by 36

  23. Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick Hwu, Scott E. Woodman, Lynda Chin, Hussein A. Tawbi, Michael A. Davies, Jeffrey E. Gershenwald, Rodabe N. Amaria, Isabella C. Glitza, Adi Diab, Sapna P. Patel, Jianhua Hu, Jeffrey E. Lee, Elizabeth A. Grimm, Michael T. Tetzlaff, Alexander J. Lazar, Ignacio I. Wistuba, Karen Clise-Dwyer, Brett W. Carter, Jianhua Zhang, P. Andrew Futreal, Padmanee Sharma, James P. Allison, Zachary A. Cooper, Jennifer A. Wargo - npj Genomic Medicine 2017 cited by 189

  24. The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 cited by 98